2026
Case Study
Revilico Virtual Cell Engine: Cross-Cell-Line Drug Response Benchmarking
Evaluating the Virtual Cell’s ability to predict half-maximal inhibitory concentration (IC50) across diverse cancer cell lines and structurally novel compounds, using publicly available drug sensitivity data and prospective experimental cell viability assay validation.
If the PDF doesn’t display, open it in a new tab or download it.

